Medical Design Briefs - September 2023 - 4

How One Company Is Using AI to Disrupt Traditional Medtech
P
roprio, a Seattle-based surgical technology
company, achieved a significant
milestone this year when its flagship
surgical navigation platform,
Paradigm™ obtained FDA 510(k) clearance.
Paradigm, the company says, harnesses
the power of light field technology
and artificial intelligence (AI) to
generate a real- time 3D visualization of
surgery. It provides surgeons with Volumetric
Intelligence™, which combines
medical images with live data from the
platform's sensor suite.
The system eliminates the need for intraoperative
scans, reducing radiation
exposure to the patient and surgical staff.
Proprio says this saves up to 30 minutes
per procedure, increasing the availability
of care to patients. By quickly registering
imaging data to the anatomy within surgical
workflows, Paradigm delivers a high
degree of accuracy and enables surgeons
to maintain focus on the patient.
" Our unique approach to surgical navigation
combines the power of AI with
advanced imaging sensors and light field
technology, " Gabriel Jones, CEO and
co-founder of Proprio says. " By leveraging
AI's data analysis and predictive learning
capabilities, the Paradigm system
merges views from multimodal sensors
and cameras, creating a real-time 3D view
of patient's anatomy, ultimately enabling
surgeons to more precisely and efficiently
navigate the surgical environment. "
The system's live, 3D, multimodal data
differs greatly from current static approaches
to surgical navigation, and the
company plans to apply its technology to
many surgical specialties beyond its first
targets in spine procedures.
Proprio recently secured $43 million
in Series B funding from new and existing
investors. The capital fuels commercialization
to address significant demand
for the AI-driven surgical navigation
platform.
" For some time, we have been searching
for a company that has the potential
to disrupt traditional medical device
businesses at scale with data, says Alf
Grunwald, executive advisor of Bird B.
AG, a global investment partnership with
significant surgical software and medical
device investments in both public and
private markets. " Proprio represents
that kind of opportunity, and we are
honored to join the investment group. "
" We are just beginning to reveal the
potential applications of Proprio's technology
and data, " says Jones. " This investment
arrives at a pivotal moment, as
we perform our first-in-human cases and
bring Paradigm to patients around the
world. Together, these milestones are a
testament to the unparalleled capabilities
of the Proprio Paradigm and its potential
to revolutionize surgery. "
Sherrie Trigg
Editor and Director of Medical Content
For more information, contact Proprio
at contact@propiovision.com or visit
www.propiovision.com.
4
www.medicaldesignbriefs.com
Medical Design Briefs, September 2023
http://www.propiovision.com http://info.hotims.com/84483-805 http://www.medicaldesignbriefs.com
Medical Design Briefs - September 2023

Table of Contents for the Digital Edition of Medical Design Briefs - September 2023
